Providing Advanced Solutions to Your Molecular and Immunological Needs
Tetracore is a biotechnology research and development organization that develops highly innovative diagnostic reagents and assays for infectious diseases and biological warfare (BW) threat
agents. The company focuses on antibody-based and nucleic acid-based detection reagents and technologies. Tetracore offers a broad range of highly-specific, rapid, antibody-based test
kits and antibody reagents for the detection of BW infectious agents and toxins, including the first FDA cleared test kit for identification of B. anthracis from colonies. Tetracore
also offers a product line of real-time, probe hydrolysis Polymerase Chain Reaction (PCR) test kits for sensitive and specific detection of animal pathogens. In addition, Tetracore contracts
with the US Government for development of: real-time PCR diagnostic tests for BW agents, novel nucleic acid extraction procedures, and specialized nucleic acid products.
The four founding scientists, Gary Long, Ph. D., Beverly L. Mangold, Ph.D.*, Thomas W. O'Brien, Ph.D., and William M. Nelson, M.D. (CDR, US Navy Ret.), have been leaders in the development
of state-of-the-art diagnostic technology for use by the Joint Program Office for Bio-defense (JPO), the Department of Defense (DOD), FBI, and DOE. These scientists bring their extensive
expertise and skills to Tetracore Inc. in order to provide these same organizations with an expanded production capability, greater flexibility in the development of new technology, and
the ability to innovate in an entrepreneurial atmosphere
Tetracore's strong scientific team and powerful technology base positions the company at the forefront in the development and production of today's important detection tools for Clinical,
Veterinary, and Domestic Preparedness Testing.
*deceased November 21, 2013